Judy Holmes
(315) 443-8085
A research paper by Syracuse University biologist Michael Cosgrove, assistant professor in The College of Arts and Sciences, was designated as the Paper of the Week in the Sept. 4 issue of the Journal of Biological Chemistry (JBC), published by the American Society for Biochemistry and Molecular Biology. Only the top 1 percent of the more than 6,600 articles published each year in JBC receive this prestigious designation.
The paper describes the discovery of a second molecular switch within the mixed lineage leukemia (MLL) protein complex that the researchers believe could be exploited to prevent the overproduction of abnormal cells that are found in several types of cancer, including leukemia. Anamika Patel, a postdoctoral researcher in Cosgrove’s lab, who is being featured on JBC’s website, did much of the experimental work for the paper.
During the course of their research to better understand MLL, a protein switch that helps regulate the formation of white blood cells, members of Cosgrove’s research group discovered a new molecular switch within the MLL complex, which they labeled W-RAD.
“We thought that MLL was the only switching mechanism present in this protein complex,” Cosgrove says. “However, we discovered the complex is really two switches.”
In normal cells, MLL combines with four proteins that comprise the W-RAD group to create a molecular switch that controls DNA packaging events required to form white blood cells. When the MLL switch is broken, white blood cells do not mature properly, resulting in a dangerous proliferation of abnormal cells.
Similarly, the proteins that form the W-RAD complex are overproduced in several types of cancer cells, but until now scientists did not know the function of these proteins. Cosgrove’s group discovered that the W-RAD proteins form a new kind of switch—one that has never been seen before.
“The W-RAD switching mechanism signals the cell to create multiple copies of cancer cells,” Cosgrove says. “If we can find a way to turn off this switch, we might be able to slow or stop the production of abnormal cells and convert them to normal cells.”
In October 2008, Cosgrove’s research group broke new ground in leukemia research by identifying a way to attack a broken MLL switch using a synthetic peptide. The peptide may be able to reprogram the way DNA is packaged in leukemia cells and help convert abnormal cells into normal ones. That research was also published in the Journal of Biological Chemistry. In June, Cosgrove received a $720,000 Research Scholar Grant from the American Cancer Society to expand his work in leukemia research.
June 05, 2012 The program, designed in collaboration with the Casting Society of America, was developed for casting students, including key professional components and core courses with fellow Tepper students.
Read more
August 24, 2012 Natalie Teale, a senior Earth sciences and geography major in Syracuse University’s College of Arts and Sciences, spent the summer as part of an immersive research experience in the cloud forest of Costa Rica.
Read more
September 13, 2012 Syracuse University today announced that it has surpassed its goal for the most ambitious fundraising effort in the institution’s history.
Read more
September 10, 2012 Civil engineering professor Cliff Davidson had a breathtaking view of the City of Syracuse from a rooftop garden recently. But it’s the possibilities of that prime location that made the experience memorable.
Read more
September 10, 2012 Trauma, psychiatric medications, family therapy, nutrition and systems reform are a sampling of the topics experts from across the country will discuss at the Children’s Mental Health Summit, September 27-29 in Syracuse.
Read more
